CARDIAC IMPLANT DEVICES MARKET

ANALYSIS WITH FORECAST (2015-2020)

By Devices (Pacemakers, Icds, Crts, Coronary Stents, Heart Valves, Tavi

Valves); By Condition (Myocardial Ischemia, Arrhythmias, Acute
Myocardial Infarction)

www.industryarc.com

To Enquire About
the Report Click
Here

TABLE OF CONTENTS
1. Cardiac Implant Devices Market Overview
2. Executive Summary
3. Cardiac Implant Devices - Market Landscape
3.1. Market Share Analysis
3.2. Comparative Analysis
3.2.1. Product Benchmarking
3.2.2. Patent Analysis
3.2.3. End user profiling
3.2.4. Top 5 Financials Analysis
4. Cardiac Implant Devices - Market Forces
4.1. Market Drivers
4.2. Market Constraints
4.3. Market Challenges
4.4. Attractiveness of the Industry
4.4.1. Power of Suppliers
4.4.2. Power of Customers
4.4.3. Threat of New entrants
4.4.4. Threat of Substitution
4.4.5. Degree of Competition
5. Cardiac Implant Devices Market Strategic Analysis
5.1. Value Chain Analysis
5.2. Opportunities Analysis
5.3. Product lifecycle
5.4. Pricing Analysis
6. Cardiac Implant Devices Market By Devices
6.1. Cardiac Resynchronization Therapy Devices (CRTS)
6.2. Implantable Cardioverter Defibrillators (ICDS)
6.3. Implantable Cardiac Pacemakers (ICPs)

To Enquire About
the Report Click
Here

6.4. Coronary Stents

6.5. Heart Valve Replacement/Repair Devices
6.6. TAVR (Transcatheter Aortic Valve Replacement) Valves
7. Cardiac Implant Devices Market- By Disease Conditions
7.1. Myocardial Ischemia
7.2. Acute Myocardial Infarction
7.3. Arrhythmias
7.4. Others
8. Cardiac Implant Devices Market Classification- By Procedure
8.1. Cardiac Resynchronization Therapy (CRT)
8.2. Minimally Invasive Heart Surgery
8.3. Open heart surgery
8.4. Angioplasty
8.5. Heart Valve Repair or Replacement
8.6. Others
9. Cardiac Implant Devices Market -Geographic Analysis
9.1. North America
9.1.1. USA
9.1.2. Canada
9.1.3. Mexico
9.1.4. Others
9.2. Europe
9.2.1. France
9.2.2. Germany
9.2.3. Italy
9.2.4. Spain
9.2.5. U.K
9.2.6. Others
9.3. APAC

To Enquire About
the Report Click
Here

9.3.1. China
9.3.2. India
9.3.3. Japan
9.3.4. Australia
9.3.5. Others
9.4. ROW
9.4.1. South Africa
9.4.2. Russia
9.4.3. Middle East
9.4.4. Others
10. Market Entropy
10.1. New Product Launches
10.2. M&As, Collaborations, JVs and Partnerships
11. Company profiles
11.1. Abbott Vascular Inc.
11.2. Medtronic, Inc.
11.3. Biotronik, Inc.
11.4. Bentley InnoMed GmbH
11.5. Elestim-Cardio
11.6. Cardioelectronica GmbH
11.7. Qualimed Innovative Medizinprodukte Gmbh
11.8. Medico S.p.A
11.9. Lepu Medical Technology
11.10. Boston Scientific Corporation
11.11. St. Jude Medical, Inc.
11.12. Edwards Lifesciences Corporation
11.13. Biosensors International Group, Ltd.
11.14. Japan Lifeline Co., Ltd.
11.15. Sorin S.p.A.

To Enquire About
the Report Click
Here

11.16. JenaValve Technology Inc.

11.17. Opto Circuits Limited
11.18. Hexacath
11.19. MicroPort Scientific Corporation.
11.20. Cardionovum GmbH
11.21. Alvimedica
11.22. Amaranth Medical
11.23. Stentys SA
12. Appendix
12.1. Abbreviations
12.2. Sources
12.3. Research Methodology
12.4. Bibliography
12.5. Compilation of Expert Insights
12.6. Disclaimer

To Enquire About
the Report Click
Here

LIST OF TABLES
Table 1

Product Benchmarking, Coronary Stents

Table 2

Product Benchmarking, Implantable Cardiac Pacemakers

Table 3

Product Benchmarking, Implantable Cardioverter Defibrillators (Icd)

Table 4

Product Benchmarking, Cardiac Resynchronization Therapy (Crt)

Table 5

Product Benchmarking, Heart Valves

Table 6

Product Benchmarking, Transcatheter Aortic Valves Replacement Valves

Table 7

Cardiac Implants Devices Market, Top Five Financial Analysis

Table 8

Cardiac Implants Devices Market, By Devices, By Value, 2014 2020

($Million)

Table 9

Cardiac Implants Devices Market, By Devices, By Volume, 2014 2020 (In

Units)

Table 10 Cardiac Implants Devices Market, Crt, By Region, By Value, 2014 2020
($Million)
Table 11

Cardiac Implants Devices Market Value, Icd, By Region, By Value, 2014 2020
($Million)

Table 12 Cardiac Implants Devices Market, Pacemakers, By Region, By Value, 2014 2020
($Million)
Table 13 Coronary Stents Based Cardiac Implant Devices Market Value, By Geography, 2014
2020 ($Million)
Table 14 Heart Valves Based Cardiac Implantable Devices Market Value, By Geography, 2014
2020 ($Million)
Table 15 Tavr (Transcatheter Aortic Valve Replacement) Based Cardiac Implantable Devices
Market Value, By Geography, 2014 2020 ($Million)
Table 16 Cardiac

Implants

Devices

Market,

By

Value,

By

Regions,

2014-2020

($Million)
Table 17 Cardiac Implants Devices Market, By Volume, By Regions, 2014-2020 (In
Units)
Table 18 Cardiac Implants Devices Market, Americas, By Value, 2014-2020 ($Million)
Table 19 Cardiac Implants Devices Market, Americas, By Volume, 2014-2020 (In Units)

To Enquire About
the Report Click
Here

Table 20 Cardiac Implants Devices Market, By Devices, Americas, 20142020 ($Million)

Table 21 Cardiac Implants Devices Market, By Value, Europe, 2014-2020 ($Million)
Table 22 Cardiac Implants Devices Market, By Volume, Europe, 2014-2020 (In Units)
Table 23 Cardiac Implants Devices Market, By Devices, Europe, 2014-2020 ($Million)
Table 24 Cardiac Implants Devices Market, By Value, Asia-Pacific, 2014-2020 ($Million)
Table 25 Cardiac Implants Devices Market, By Volume, Asia-Pacific, 2014-2020 (In
Units)
Table 26 Cardiac

Implants

Devices

Market,

By

Device,

Asia-Pacific,

($Million)
Table 27 Cardiac Implants Devices Market, By Value, Row, 2014-2020 ($Million)
Table 28 Cardiac Implants Devices Market, By Volume, Row, 2014-2020 (In Units)
Table 29 Cardiac Implants Devices Market, By Device, Row, 2014-2020 ($Million)
Table 30 Cardiac Implants Devices Market, Key Product Launches
Table 31 Cardiac Implants Devices Market, Key Partnerships
Table 32 Cardiac Implants Devices Market, Key Acquisitions
Table 33 Abbott Vascular Inc., Products
Table 34 Abbott Vascular Inc., Developments
Table 35 Medtronic, Inc., Products
Table 36 Medtronic, Inc., Developments
Table 37 Biotronik, Inc., Products
Table 38 Biotronik, Inc., Developments
Table 39 Bentley InnoMed GmbH, Products
Table 40 Bentley InnoMed GmbH, Developments
Table 41 Elestim-Cardio, Products
Table 42 Elestim-Cardio, Developments
Table 43 Cardioelectronica GmbH, Products
Table 44 Cardioelectronica GmbH, Developments
Table 45 Qualimed Innovative Medizinprodukte Gmbh, Products
Table 46 Qualimed Innovative Medizinprodukte Gmbh, Developments
Table 47 Medico S.p.A, Products, Products
Table 48 Medico S.p.A, Products, Developments

2014-2020

To Enquire About
the Report Click
Here

Table 49 Lepu Medical Technology, Products

Table 50 Lepu Medical Technology, Developments
Table 51 Boston Scientific Corporation, Products
Table 52 Boston Scientific Corporation, Developments
Table 53 St. Jude Medical, Inc., Products
Table 54 St. Jude Medical, Inc., Developments
Table 55 Edwards Lifesciences Corporation, Products
Table 56 Edwards Lifesciences Corporation, Developments
Table 57 Biosensors International Group, Ltd., Products
Table 58 Biosensors International Group, Ltd., Developments
Table 59 Japan Lifeline Co., Ltd., Products
Table 60 Japan Lifeline Co., Ltd., Developments
Table 61 Sorin S.p.A., Products
Table 62 Sorin S.p.A., Developments
Table 63 JenaValve Technology Inc., Products
Table 64 JenaValve Technology Inc., Developments
Table 65 Opto Circuits Limited, Products
Table 66 Opto Circuits Limited, Developments
Table 67 Hexacath, Products
Table 68 Hexacath, Developments
Table 69 MicroPort Scientific Corporation. Products
Table 70 MicroPort Scientific Corporation. Developments
Table 71 Cardionovum GmbH, Products
Table 72 Cardionovum GmbH, Developments
Table 73 Alvimedica, Products
Table 74 Alvimedica, Developments
Table 75 Amaranth Medical, Products
Table 76 Amaranth Medical, Developments
Table 77 Stentys SA, Products
Table 78 Stentys SA, Developments

To Enquire About
the Report Click
Here

LIST OF FIGURES
Figure1

Cardiac Implantable Devices Market Classification, By Disease Conditions

Figure2

Cardiac Implant Devices Market Classification, By Treatment Options

Figure3

Cardiac

Implantable

Devices

Market

Classification,

By

Cardiac

Implant

Devices
Figure4

Cardiac Implantable Monitoring Devices

Figure5

Cardiac Implant Devices Market Revenue By Geographic Region, 2014 (%)

Figure6

Cardiac Implantable Devices Market, Share Analysis, 2014 (%)

Figure7

Patent Analysis

Figure8

Cardiac Implantable Devices Market - Value Chain Analysis

Figure9

Cardiac Implantable Devices Market Partnerships, 2011-14 (%)

Figure10 Number Of Acquisitions

Figure11 Abbott vascular inc.: Financial Performance, Total Revenues 2011-2014, ($Billion)
Figure12 Abbott vascular inc.: Total Revenue, By Region, 2014 (%)
Figure13 Abbott vascular inc.: Total Revenue, By Segments, 2014 (%)
Figure14 Financial Performance, Total Revenues, 2010-2014, ($Billion)
Figure15 Financial Performance, Cardiovascular Revenues, 2010-2014, ($Billion)
Figure16 Johnson & Johnson: Total Revenue, By Region, 2014 (%)
Figure17 Johnson & Johnson: Total Revenue, By Segment, 2014 (%)
Figure18 Financial Performance, Total Revenues, 2011- 2014 ($Million)
Figure19 Financial Performance, Total Revenues, 2010-2014, ($Billion)
Figure20 Medtronic plc. Total revenue, by region, 2014 (%)
Figure21 Medtronic Plc.Total Revenue, By Segments, 2014 (%)
Figure22 Boston Scientific Corporation: Financial Performance, 2010-2014, ($Billion)
Figure23 Boston Scientific Corporation: Total Revenue, By Segments, 2014 (%)
Figure24 Boston Scientific Corporation: Total Revenue, By Region, 2014 (%)
Figure25 St. Jude medical, inc.: Financial Performance, 2011-2014, ($Billion)
Figure26 St. Jude medical, inc.: Total Revenue, By Region, 2014 (%)
Figure27 St. Jude medical, inc.: Total Revenue, By Segments, 2014 (%)
Figure28 Edwards Lifesciences Corporation: Financial Performance, 2011-2014, ($Billion)
Figure29 Edwards Lifesciences Corporation, Total Revenue, By Segments, 2014 (%)

To Enquire About
the Report Click
Here

Figure30 Edwards lifesciences corporation, total revenue, by region, 2014

(%)
Figure31 B. Braun melsungen ag: total revenue, 2011-2014, ($billion)
Figure32 B. Braun melsungen: total revenue, by segments, 2014 (%)
Figure33 B. Braun melsungen: total revenue, by region, 2014 (%)
Figure34 Biosensors international group, ltd.: financial performance, 2011-2014, ($million)
Figure35 Biosensors international group, ltd.: total revenue, by segment, 2014 (%)
Figure36 Biosensors international group, ltd.: total revenue, by region, 2014 (%)
Figure37 Atrium Medical Corporation: Financial Performance, 2011-2014, ($Billion)
Figure38 Atrium Medical Corporation: Total Revenue, By Segments, 2014 (%)
Figure39 Atrium Medical Corporation: Total Revenue, By Region, 2014 (%)
Figure40 Abiomed, inc.: Financial Performance, 2011-2014, ($Million)
Figure41 Abiomed, inc.: Total Revenue, By Region, 2014 (%)
Figure42 Japan lifeline co., ltd. : Financial Performance, 2011-2014, ($Million)
Figure43 Japan lifeline co., ltd.: Total Revenue, By Segments, 2014 (%)
Figure44 Financial Performance, 2011-2014, ($Billion)
Figure45 Teleflex Incorporated: Total Revenue, By Segments, 2014 (%)
Figure46 Teleflex Incorporated: Total Revenue, By Region, 2014 (%)
Figure47 C.R.Bard Inc.: Financial Performance, 2011-2014, ($Billion)
Figure48 C.R.Bard Inc.: Total Revenue, By Segments, 2014 (%)
Figure49 Financial Performance, 2011-2014, ($Billion)
Figure50 Sorin s.p.a. Total revenue, by region, 2014 (%)
Figure51 Sorin s.p.a. Total revenue, by segments, 2014 (%)
Figure52 Qt vascular ltd.: Financial Performance, 2012-2014, ($ m)
Figure53 Qt vascular ltd.: total revenue, by region, 2014 (%)

To Enquire About
the Report Click
Here

KEY INSIGHTS
The Cardiac Implantable Devices Market is growing at a CAGR of 12.5% during
the forecast period 2015-2020.
In recent years 3D printing technology is being utilized to perform virtual surgeries for
proper stent implantation in percutaneous coronary intervention procedures, to reduce
the risk of in-stent restenosis.
America is the current market leader followed by Europe. Heart disease is the major
cause of death for American population, killing millions of people every year.
Depression and anxiety has been found as the major risk factor for development of
cardiovascular

diseases.

According

to

NIH

(National

Institute

of

Mental

Health) depression is one of the common mental illnesses in the United States, affecting
one in ten Americans at one point or another in lifetime.
The cardiac implantable devices market will witness an enormous growth rate in APAC
due to surge in chronic diseases which can be addressed relatively better now due to the
improved economy, better infrastructure and trained professionals.
Among cardiac implantable devices, coronary stents devices are generating the
largest revenue whereas in future TAVR (Transcatheter Aortic Valve Replacement)
valves will capture majority market share.
The key players in this market are Medtronic, Inc., Boston Scientific Corporation, St.
Jude Medical, Inc., Abbott Vascular Inc. and Edwards Lifesciences Corporation.

To Enquire About
the Report Click
Here

RESEARCH METHODOLOGY
The quantitative and qualitative data collected for the global Cardiac Implant Devices report is from
a combination of secondary and primary sources. Research interviews were conducted with
executives and/or mangers in the key product manufacturers and related organizations. These Key
Opinion Leaders (KOLs) were then provided a questionnaire to gather quantitative and qualitative
inputs on their operations, performance, strategies and views on the overall market, including key
developments and trends. Data from interviews is consolidated, checked for consistency and
accuracy, and the final market numbers are again validated by experts. The global Cardiac Implant
Devices was split by grades of polycarbonate resins, applications and geography based on different
factors like primary and secondary sources, understanding of the number of companies operating in
each segment and also KOL insights.
We have used various secondary sources such as directories, articles, white papers, newsletters,
annual reports and paid databases such as OneSource, Hoovers and Factiva to identify and collect
information for extensive commercial study of the global Cardiac Implant Devices.
The approach towards finding information regarding the market and forecasting has been quite
extensive. The key players in the market and its value chain were identified through secondary
research and their market opinions were also gathered in a similar way through telephonic interviews
and questionnaires. Interviews with key opinion leaders such as managers and marketing personnel
were used extensively in understanding the need and emergence of polycarbonate resin market.
We also have extensive database of contacts which were used to conduct primary interviews and
also to get their inputs using questionnaires.

To Enquire About
the Report Click
Here

THE ARC ADVANTAGE

An analytical model lies at the core of our process, ensuring logical consistency throughout
our research. We complement the model with secondary data and interviews with industry
experts to reflect the latest trends. With our final expert validation, we provide you with
only the most accurate and actionable intelligence.

THE ARC PROCESS

Analytical
Method
1. Granular
breakdown of
drivers into
factors
2. Validate all
factors in terms
of their present
impact on the
market
3. Assign weights
to these factors in
terms of their
relevance and
impact on the
market
4. Build the
Analytical Model
ANALYTICAL MODEL

Base Method

1. Get a topdown estimate of

the market
2. Follow it up
with a bottom-up
estimate of the
market
3. Check
forconsistency
and new growth
factors that are
relevant over the
next 10 Years

4. Build the Base

model
BASE MODEL

Consolidation
Method
1. Granular
breakdown of
drivers into
factors
2. Validate all
factors in terms
of their present
impact on the
market.
3. Assign weights
to these factors in
terms of their
relevance and
impact on the
market.
4. Build the
Consolidated
Model

Delphi
Verification
1. Verify the
findings of the
model with
experts from
across the value
chain
2. Verify the
findings with
players across
small and large
enterprises
3. Tweak the
model and add
new factors
4. Finalize the
ARC Model

CONSOLIDATED MODEL

ARC MODEL

To Enquire About
the Report Click
Here

ABOUT US
IndustryARC was started by a group of young, passionate professionals along with extensively
experienced industry veterans across various business segments. Our focus and expertise is
mainly in the field of analytics, market research and consulting. Our singular goal is to provide
accurate and affordable research to our clients.
Our research team has expertise in diverse fields like Automotive, Chemicals,Consumer
Product & Services, Electronics, Food & Beverages, Healthcare etc., However diverse the
expertise maybe, everyone in our team shares one common trait - we love data and we love
providing solutions to clients using that data even more! Seeing your business flourish based
on our solutions and strategy is what we love the most!
IndustryARC publishes more than 30 reports on an annual basis in the mentioned Industries.
Our reports are in-depth and high quality reports that can help decision makers frame better
strategies for their business requirements. These reports can be further customized as per your
needs.
Disclaimer:

The reports sold by IndustryARC are limited publications containing valuable market
information provided to a select group of customers in response to orders.

Our customers acknowledge and agree that any report bought from IndustryARC is for
their own internal use and not for general publication or disclosure to third parties.

Our reports or part of the reports, information contained in the report, cannot be
shared or resold to any other third party.

Disclosure to third parties, usage of data in a public document, article or blog by the
customer can be done with prior permission taken from IndustryARC.

For information regarding permissions and sales, contact:

sales@industryarc.com | sanjay.matthews@industryarc.com

To Enquire About
the Report Click
Here

IndustryARC
+1 614 - 588 - 8538
sales@industryarc.com

Copyright 2015 IndustryARC

All Rights Reserved. This document contains highly confidential information and is the sole
property of IndustryARC. No part of it may be circulated, copied, quoted, or otherwise reproduced
without the approval of IndustryARC.